Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Weiden

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Oncology (Williston Park, N.Y.)|April 29, 1998
Initial control of chemotherapy-induced nausea and vomiting in patient quality of lifeG R Morrow, J A Roscoe, J T Hickok, et al.
Experimental Hematology|January 1, 1983
Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemiaM S Tsoi, R P Warren, R Storb, et al.
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Blood|August 1, 1988
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationK M Sullivan, R P Witherspoon, R Storb, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experienceC D Buckner, A Fefer, W I Bensinger, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancerF Gutierrez-Delgado, L A Holmberg, H Hooper, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Oncology (Williston Park, N.Y.)|April 29, 1998
Initial control of chemotherapy-induced nausea and vomiting in patient quality of lifeG R Morrow, J A Roscoe, J T Hickok, et al.
Experimental Hematology|January 1, 1983
Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemiaM S Tsoi, R P Warren, R Storb, et al.
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Blood|August 1, 1988
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationK M Sullivan, R P Witherspoon, R Storb, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experienceC D Buckner, A Fefer, W I Bensinger, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancerF Gutierrez-Delgado, L A Holmberg, H Hooper, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Bone Marrow Transplantation|June 1, 1997
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancerW I Bensinger, K S Schiffman, L Holmberg, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Pageof 3